INCYTE CORP

Route 141 & Henry Clay Rd, Bldg E336 Ticker: INCY
Wilmington , DE 19804 Exchange: NASD
302-498-6700 Sector: Health Care
Industry: Biotechnology

Complete Financials: Q4Y09 Currency: USD Current Annual Period: Y08
Business Summary
INCY Incyte Corporation, a drug discovery and development company, focuses on developing proprietary small molecule drugs to treat oncology, inflammation, and diabetes.


RATIOS AND STATISTICS AT A GLANCE
( As of 03/11/2010 )
Price

52 Week High

52 Week Low

3 Month Avg Daily Vol (Mil)

10 Day Avg Daily Vol (Mil)

Beta

Indicated Annual Dividend

Dividend Yield % 		11.340

11.740

1.960

2.749

1.758

2.477

0.000

0.000 		Price/Sales (TTM)

P/E Ratio (TTM)

Price/Book (MRQ)

Price/Cash Flow (TTM)

Return on Assets (TTM) %

Return on Equity (TTM) %

Current Ratio (MRQ)

Total Debt/Equity (MRQ) 		NA

NC

-12.342

NA

-55.252

99.713

9.094

-4.328

Note:
Mil = Millions
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months


SHARE RELATED INFORMATION SHORT INTEREST INFORMATION
Market Cap (Mil)

Shares Outstanding (Mil)

Float (Mil) 		1,344.244

118.540

90.768 		Current Month (Mil)

Previous Month (Mil)

Short Interest Ratio (Days) 		21.377

20.406

NA


INSTITUTIONAL &
INSIDER OWNERSHIP 		PURCHASES
(Mil) 		SALES
(Mil) 		NET PURCHASES
(Mil) 		PERCENT
OWNED (%) 		PREVIOUS PERCENT
OWNED (%)
Institutions (3 Months)

Insiders (6 Months) 		27.209

0.000 		-17.718

0.022 		9.491

-0.022 		97.759

23.428 		90.293

NA


GROWTH RATES 1 YEAR 3 YEAR 5 YEAR
Sales %

EPS %

Dividend % 		-88.621

NC

NC 		-20.657

NC

NC 		-39.180

NC

NC


HISTORICAL QUARTERLY RESULTS

REVENUE
( Thousands of USD )
QUARTERS 2006 2007 2008 2009
Q1

Q2

Q3

Q4 		6.465

6.855

7.267

7.056 		7.422

10.576

6.690

9.752 		1.307

0.613

1.061

0.938 		0.671

0.789

0.939

6.866
TOTAL 27.643 34.440 3.919 9.265
EARNINGS PER SHARE
( USD )
QUARTERS 2006 2007 2008 2009
Q1

Q2

Q3

Q4 		-0.210

-0.240

-0.190

-0.240 		-0.260

-0.220

-0.290

-0.260 		-0.470

-0.540

-0.480

-0.500 		-0.410

-0.410

-0.440

-0.740
TOTAL -0.880 -1.030 -1.990 -2.000

Copyright © 2010 , Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. Standard & Poor’s including its subsidiary corporations (“S&P”) is a division of The McGraw-Hill Companies, Inc. Reproduction of S&P Compustat in any form is prohibited except with the prior written permission of S&P. Because of the possibility of human or mechanical error by S&P’s sources, S&P or others, S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. S&P GIVES NO EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any indirect, special or consequential damages in connection with subscriber’s or others’ use of S&P Compustat.